Itraconazole solution
Itraconazole solution is mainly composed of Itraconazole (HY-17514). Itraconazole (R51211) is a triazole antifungal agent and a potent and orally active Hedgehog (Hh) signaling pathway antagonist with an IC50 of ~800 nM. Itraconazole potently inhibits lanosterol 14α-demethylase (cytochrome P450 enzyme), thereby inhibits the oxidative conversion of lanosterol to ergosterol. Itraconazole has anticancer and antiangiogenic effects. Itraconazole is a oxysterol-binding protein (OSBP) inhibitor.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 84625-61-6
- Fòrmula: C35H38Cl2N8O4
- Peso molecular:705.63
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas Antibiotic
More
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 84625-61-6
-
Peso molecular 705.63
-
Fòrmula C35H38Cl2N8O4
-
SMILES
ClC1=C([C@]2(CN3C=NC=N3)O[C@H](CO2)COC4=CC=C(C=C4)N5CCN(CC5)C6=CC=C(C=C6)N(C7=O)C=NN7C(CC)C)C=CC(Cl)=C1
-
Synonyms
R51211 solution
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Kim, J., et al., Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell, 2010. 17(4): p. 388-99. [Content Brief]
[2]. Chong, C.R., et al., Inhibition of angiogenesis by the antifungal drug itraconazole. ACS Chem Biol, 2007. 2(4): p. 263-70. [Content Brief]
[3]. Pace JR, et al. Repurposing the Clinically Efficacious Antifungal Agent Itraconazole as an Anticancer Chemotherapeutic. J Med Chem. 2016 Apr 28;59(8):3635-49. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)